News
Watch this webinar to hear from Dr. Steven Corsello, MD, Founder of the Drug Repurposing Hub at the Broad Institute, Cambridge. In this webinar, Dr. Corsello will discuss the Drug Repurposing Hub, an open-access repository of more than 6000 compounds, many of which have been FDA approved, and his experience strategizing candidates for drug repurposing for cancer therapeutics.
Dr. Steven Corsello, MD, Founder, Drug Repurposing Hub
Dr. Corsello is the founder of the Drug Repurposing Hub at the Broad Institute and an attending physician at the Dana-Farber Cancer Institute. He currently leads an effort to evaluate all available clinical drugs using information-rich cellular assays and to develop new cancer treatments. As a key contributor to the Connectivity Map Project, he also develops translational applications for perturbational gene expression profiling.
Dr. Corsello holds an A.B. in biochemical sciences from Harvard College and an MD from Harvard Medical School, where he developed gene expression-based screening approaches for leukemia. He completed residency training in internal medicine at Massachusetts General Hospital and a combined fellowship program in hematology and medical oncology at the Dana-Farber-Cancer Institute.
*This webinar is a part of the Drug Repurposing Series
